Cargando…
COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity
We examine heterogeneity in COVID-19 vaccine hesitancy across eight European countries. We reveal striking differences across countries, ranging from 6.4% of adults in Spain to 61.8% in Bulgaria reporting being hesitant. We experimentally assess the effectiveness of different messages designed to re...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045608/ https://www.ncbi.nlm.nih.gov/pubmed/35476432 http://dx.doi.org/10.1126/sciadv.abm9825 |
_version_ | 1784695351494574080 |
---|---|
author | Steinert, Janina I. Sternberg, Henrike Prince, Hannah Fasolo, Barbara Galizzi, Matteo M. Büthe, Tim Veltri, Giuseppe A. |
author_facet | Steinert, Janina I. Sternberg, Henrike Prince, Hannah Fasolo, Barbara Galizzi, Matteo M. Büthe, Tim Veltri, Giuseppe A. |
author_sort | Steinert, Janina I. |
collection | PubMed |
description | We examine heterogeneity in COVID-19 vaccine hesitancy across eight European countries. We reveal striking differences across countries, ranging from 6.4% of adults in Spain to 61.8% in Bulgaria reporting being hesitant. We experimentally assess the effectiveness of different messages designed to reduce COVID-19 vaccine hesitancy. Receiving messages emphasizing either the medical benefits or the hedonistic benefits of vaccination significantly increases COVID-19 vaccination willingness in Germany, whereas highlighting privileges contingent on holding a vaccination certificate increases vaccination willingness in both Germany and the United Kingdom. No message has significant positive effects in any other country. Machine learning–based heterogeneity analyses reveal that treatment effects are smaller or even negative in settings marked by high conspiracy beliefs and low health literacy. In contrast, trust in government increases treatment effects in some groups. The heterogeneity in vaccine hesitancy and responses to different messages suggests that health authorities should avoid one-size-fits-all vaccination campaigns. |
format | Online Article Text |
id | pubmed-9045608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-90456082022-05-04 COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity Steinert, Janina I. Sternberg, Henrike Prince, Hannah Fasolo, Barbara Galizzi, Matteo M. Büthe, Tim Veltri, Giuseppe A. Sci Adv Social and Interdisciplinary Sciences We examine heterogeneity in COVID-19 vaccine hesitancy across eight European countries. We reveal striking differences across countries, ranging from 6.4% of adults in Spain to 61.8% in Bulgaria reporting being hesitant. We experimentally assess the effectiveness of different messages designed to reduce COVID-19 vaccine hesitancy. Receiving messages emphasizing either the medical benefits or the hedonistic benefits of vaccination significantly increases COVID-19 vaccination willingness in Germany, whereas highlighting privileges contingent on holding a vaccination certificate increases vaccination willingness in both Germany and the United Kingdom. No message has significant positive effects in any other country. Machine learning–based heterogeneity analyses reveal that treatment effects are smaller or even negative in settings marked by high conspiracy beliefs and low health literacy. In contrast, trust in government increases treatment effects in some groups. The heterogeneity in vaccine hesitancy and responses to different messages suggests that health authorities should avoid one-size-fits-all vaccination campaigns. American Association for the Advancement of Science 2022-04-27 /pmc/articles/PMC9045608/ /pubmed/35476432 http://dx.doi.org/10.1126/sciadv.abm9825 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Social and Interdisciplinary Sciences Steinert, Janina I. Sternberg, Henrike Prince, Hannah Fasolo, Barbara Galizzi, Matteo M. Büthe, Tim Veltri, Giuseppe A. COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity |
title | COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity |
title_full | COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity |
title_fullStr | COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity |
title_full_unstemmed | COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity |
title_short | COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity |
title_sort | covid-19 vaccine hesitancy in eight european countries: prevalence, determinants, and heterogeneity |
topic | Social and Interdisciplinary Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045608/ https://www.ncbi.nlm.nih.gov/pubmed/35476432 http://dx.doi.org/10.1126/sciadv.abm9825 |
work_keys_str_mv | AT steinertjaninai covid19vaccinehesitancyineighteuropeancountriesprevalencedeterminantsandheterogeneity AT sternberghenrike covid19vaccinehesitancyineighteuropeancountriesprevalencedeterminantsandheterogeneity AT princehannah covid19vaccinehesitancyineighteuropeancountriesprevalencedeterminantsandheterogeneity AT fasolobarbara covid19vaccinehesitancyineighteuropeancountriesprevalencedeterminantsandheterogeneity AT galizzimatteom covid19vaccinehesitancyineighteuropeancountriesprevalencedeterminantsandheterogeneity AT buthetim covid19vaccinehesitancyineighteuropeancountriesprevalencedeterminantsandheterogeneity AT veltrigiuseppea covid19vaccinehesitancyineighteuropeancountriesprevalencedeterminantsandheterogeneity |